Serological characterization of HTLV-III infection in AIDS and related disorders Journal Article


Authors: Groopman, J. E.; Chen, F. W.; Hope, J. A.; Andrews, J. M.; Swift, R. L.; Benton, C. V.; Sullivan, J. L.; Volberding, P. A.; Sites, D. P.; Landesman, S.; Gold, J.; Baker, L.; Craven, D.; Boches, F. S.
Article Title: Serological characterization of HTLV-III infection in AIDS and related disorders
Abstract: Current efforts to test blood donors and other persons for exposure to the human T cell lymphotropic virus type III (HTLV-III), the etiologic agent of the acquired immunodeficiency syndrome (AIDS), are based on the measurement of serum antibodies to viral antigens. We studied presence of serum antibodies to HTLV-III-related antigens from 767 individuals with AIDS or AIDS-related complex (ARC) or asymptomatic persons at risk for AIDS by using ELISA and immunoblot techniques. Of the 280 specimens from AIDS and ARC subjects that were tested, 99% were ELISA reactive and 96% were immunoblot reactive. Greater than 96% of the seropositive subjects manifested antibodies to the p24 core antigen, whereas only 88% had antibodies to the gp41 envelope-related glycoprotein. Contrary to previous reports, a short incubation time in the immunoblot assay failed to detect low-titer or low-affinity antibodies that were detected by overnight incubation. There was no apparent difference in pattern of antibodies to HTLV-III-related antigens in symptomatic vs. asymptomatic seropositive individuals.
Keywords: enzyme linked immunosorbent assay; risk; diagnosis; immunoblotting; acquired immune deficiency syndrome; human immunodeficiency virus 1; virus protein; virus glycoprotein; virus antibody; antibody blood level; priority journal; blood and hemopoietic system
Journal Title: Journal of Infectious Diseases
Volume: 153
Issue: 4
ISSN: 0022-1899
Publisher: Oxford University Press  
Date Published: 1986-04-01
Start Page: 736
End Page: 742
Language: English
DOI: 10.1093/infdis/153.4.736
PROVIDER: scopus
PUBMED: 3005434
DOI/URL:
Notes: Article -- Export Date: 18 August 2021 -- Source: Scopus
Altmetric
Citation Impact
BMJ Impact Analytics
MSK Authors
  1. Jonathan W. M. Gold
    73 Gold